ICRG is a leading collaborative research group in MENA (Middle East Northern Africa), pioneering research at the intersection of cancer research and medical sciences, Quantum Physics (Quantum Optics), and Artificial Intelligence. The advent of new technologies in Quantum Physics on which the group is fully focused is providing the conditions to implement personalized and targeted medicine in cancer detection and care.
ICRG is composed of a dedicated team of highly experienced professionals based in the UAE, Kingdom of Saudi Arabia, Egypt, Jordan, and Algeria running trials in the MENA region as well in Europe.
Led by Professor Jean-Marc Nabholtz from King Saud University Medical City in Riyadh (Kingdom of Saudi Arabia - KSA), the Academic group is composed of an International Scientific Committee with Key Opinion Leaders(KOLs) in oncology in the MENA region and Europe.
The responsibilities of the Academic group are summarized below.
ICRG is the only Academic Corporative Group implementing in the MENA region state-of-art Clinical Operations at the R&D level. ICRG dedicated team operates in compliance with the Industry and Government guidelines. ICRG Clinical Operations experienced team members ensure rapid study start-up, superior quality, and most efficient delivery at every phase of the trials.
ICR Group Definition
